12:00 AM
 | 
Oct 27, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ELND-006: Phase I started

Elan began a Phase I trial.

Elan Corp. plc (NYSE:ELN), Dublin,...

Read the full 39 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >